Lite Strategy, Inc.
General ticker "LITS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.2M (TTM average)
Lite Strategy, Inc. does not follow the US Stock Market performance with the rate: -25.4%.
Estimated limits based on current volatility of 5.7%: low 1.33$, high 1.50$
Short-term LITS quotes
Long-term LITS plot
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $48.82MM | $65.30MM | $0.00MM |
| Operating Expenses | $85.58MM | $50.76MM | $17.45MM |
| Operating Income | $-36.76MM | $14.54MM | $-17.45MM |
| Non-Operating Income | $4.93MM | $3.24MM | $1.51MM |
| R&D Expense | $52.45MM | $16.56MM | $3.92MM |
| Income(Loss) | $-31.84MM | $17.78MM | $-15.95MM |
| Profit(Loss)* | $-31.84MM | $17.78MM | $-15.95MM |
| Stockholders Equity | $24.62MM | $33.02MM | $16.93MM |
| Assets | $120.81MM | $41.38MM | $18.29MM |
| Operating Cash Flow | $-52.48MM | $-50.47MM | $-20.84MM |
| Capital expenditure | $0.04MM | $0.01MM | $0.00MM |
| Investing Cash Flow | $53.69MM | $49.14MM | $35.15MM |
| Financing Cash Flow | $-0.04MM | $-11.87MM | $0.00MM |
| Earnings Per Share** | $-4.78 | $2.67 | $-2.39 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.